<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>References | 97039 - GLOBAL HEALTH, ANTIMICROBIAL DRUGS AND VACCINES</title>
  <meta name="description" content="References | 97039 - GLOBAL HEALTH, ANTIMICROBIAL DRUGS AND VACCINES" />
  <meta name="generator" content="bookdown 0.24.4 and GitBook 2.6.7" />

  <meta property="og:title" content="References | 97039 - GLOBAL HEALTH, ANTIMICROBIAL DRUGS AND VACCINES" />
  <meta property="og:type" content="book" />
  
  
  
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="References | 97039 - GLOBAL HEALTH, ANTIMICROBIAL DRUGS AND VACCINES" />
  
  
  

<meta name="author" content="Russell E. Lewis, Associate Professor, Infectious Diseases, University of Bologna" />


<meta name="date" content="2022-01-17" />

  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  
  
<link rel="prev" href="lecture-slides-2.html"/>

<script src="assets/header-attrs-2.11.4/header-attrs.js"></script>
<script src="assets/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/fuse.js@6.4.6/dist/fuse.min.js"></script>
<link href="assets/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="assets/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="assets/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="assets/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="assets/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="assets/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="assets/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />








<link href="assets/anchor-sections-1.0.1/anchor-sections.css" rel="stylesheet" />
<script src="assets/anchor-sections-1.0.1/anchor-sections.js"></script>



<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li class="chapter" data-level="" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i>Welcome to the online course lecture notes</a></li>
<li class="chapter" data-level="" data-path="module-1-the-growing-pandemic-of-antimicrobial-resistance.html"><a href="module-1-the-growing-pandemic-of-antimicrobial-resistance.html"><i class="fa fa-check"></i>Module 1: The Growing Pandemic of Antimicrobial Resistance</a>
<ul>
<li class="chapter" data-level="" data-path="a-brief-history-of-antimicrobial-resistance-amr.html"><a href="a-brief-history-of-antimicrobial-resistance-amr.html"><i class="fa fa-check"></i>A brief history of antimicrobial resistance (AMR)</a></li>
<li class="chapter" data-level="" data-path="global-response-to-antimicrobial-resistance-amr.html"><a href="global-response-to-antimicrobial-resistance-amr.html"><i class="fa fa-check"></i>Global response to antimicrobial resistance (AMR)</a></li>
<li class="chapter" data-level="" data-path="what-are-the-drivers-of-antimicrobial-resistance.html"><a href="what-are-the-drivers-of-antimicrobial-resistance.html"><i class="fa fa-check"></i>What are the drivers of antimicrobial resistance?</a></li>
<li class="chapter" data-level="" data-path="amr-in-low-middle-income-countries-lmics.html"><a href="amr-in-low-middle-income-countries-lmics.html"><i class="fa fa-check"></i>AMR in Low-Middle Income Countries (LMICs)</a>
<ul>
<li class="chapter" data-level="" data-path="amr-in-low-middle-income-countries-lmics.html"><a href="amr-in-low-middle-income-countries-lmics.html#how-can-the-effectiveness-of-antimicrobials-be-preserved"><i class="fa fa-check"></i>How can the effectiveness of antimicrobials be preserved?</a></li>
<li class="chapter" data-level="" data-path="amr-in-low-middle-income-countries-lmics.html"><a href="amr-in-low-middle-income-countries-lmics.html#case-study-a-successful-national-antibiotic-stewardship-program-in-a-lmic"><i class="fa fa-check"></i>Case study: A successful national antibiotic stewardship program in a LMIC</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="amr-situation-in-italy.html"><a href="amr-situation-in-italy.html"><i class="fa fa-check"></i>AMR situation in Italy</a></li>
<li class="chapter" data-level="" data-path="the-global-future-of-amr.html"><a href="the-global-future-of-amr.html"><i class="fa fa-check"></i>The global future of AMR</a></li>
<li class="chapter" data-level="" data-path="one-health-perspective-of-amr.html"><a href="one-health-perspective-of-amr.html"><i class="fa fa-check"></i>One-Health Perspective of AMR</a>
<ul>
<li class="chapter" data-level="" data-path="one-health-perspective-of-amr.html"><a href="one-health-perspective-of-amr.html#antibiotic-use-in-animal-food-production"><i class="fa fa-check"></i>Antibiotic use in animal food production</a></li>
<li class="chapter" data-level="" data-path="one-health-perspective-of-amr.html"><a href="one-health-perspective-of-amr.html#the-impact-of-animal-antibiotic-use-on-human-amr"><i class="fa fa-check"></i>The impact of animal antibiotic use on human AMR</a></li>
<li class="chapter" data-level="" data-path="one-health-perspective-of-amr.html"><a href="one-health-perspective-of-amr.html#antimicrobial-resistance-in-animals-in-lmics"><i class="fa fa-check"></i>Antimicrobial resistance in animals in LMICs</a></li>
<li class="chapter" data-level="" data-path="one-health-perspective-of-amr.html"><a href="one-health-perspective-of-amr.html#environmental-concerns"><i class="fa fa-check"></i>Environmental concerns</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="cross-border-spread-of-amr.html"><a href="cross-border-spread-of-amr.html"><i class="fa fa-check"></i>Cross-border spread of AMR</a></li>
<li class="chapter" data-level="" data-path="summary.html"><a href="summary.html"><i class="fa fa-check"></i>Summary</a></li>
<li class="chapter" data-level="" data-path="lecture-slides.html"><a href="lecture-slides.html"><i class="fa fa-check"></i>Lecture Slides</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="module-2-the-public-health-crisis-of-new-antibiotic-development.html"><a href="module-2-the-public-health-crisis-of-new-antibiotic-development.html"><i class="fa fa-check"></i>Module 2: The Public Health Crisis of New Antibiotic Development</a>
<ul>
<li class="chapter" data-level="" data-path="background.html"><a href="background.html"><i class="fa fa-check"></i>Background</a></li>
<li class="chapter" data-level="" data-path="why-has-antibiotic-discovery-faltered-in-recent-years.html"><a href="why-has-antibiotic-discovery-faltered-in-recent-years.html"><i class="fa fa-check"></i>Why has antibiotic discovery faltered in recent years?</a>
<ul>
<li class="chapter" data-level="" data-path="why-has-antibiotic-discovery-faltered-in-recent-years.html"><a href="why-has-antibiotic-discovery-faltered-in-recent-years.html#scientific-challenges"><i class="fa fa-check"></i>Scientific challenges</a></li>
<li class="chapter" data-level="" data-path="why-has-antibiotic-discovery-faltered-in-recent-years.html"><a href="why-has-antibiotic-discovery-faltered-in-recent-years.html#antibiotic-regulatory-hurdles"><i class="fa fa-check"></i>Antibiotic regulatory hurdles</a></li>
<li class="chapter" data-level="0.0.1" data-path="why-has-antibiotic-discovery-faltered-in-recent-years.html"><a href="why-has-antibiotic-discovery-faltered-in-recent-years.html#non-inferiority-trial-designs"><i class="fa fa-check"></i><b>0.0.1</b> Non-inferiority trial designs</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="what-are-the-current-strategies-to-incentive-antibiotic-development.html"><a href="what-are-the-current-strategies-to-incentive-antibiotic-development.html"><i class="fa fa-check"></i>What are the current strategies to incentive antibiotic development?</a>
<ul>
<li class="chapter" data-level="" data-path="what-are-the-current-strategies-to-incentive-antibiotic-development.html"><a href="what-are-the-current-strategies-to-incentive-antibiotic-development.html#antibiotic-supply-chain-problems"><i class="fa fa-check"></i>Antibiotic supply chain problems</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html"><a href="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html"><i class="fa fa-check"></i>What can be done to ensure antibiotic access in LMICs?</a>
<ul>
<li class="chapter" data-level="" data-path="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html"><a href="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html#barrier-1-weak-drug-discovery-difficulties-in-market-entry-and-poor-stewardship-lead-to-irrational-selection-and-use-of-antibiotics"><i class="fa fa-check"></i>Barrier 1: Weak drug discovery, difficulties in market entry, and poor stewardship lead to irrational selection and use of antibiotics</a></li>
<li class="chapter" data-level="" data-path="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html"><a href="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html#barrier-2-antibiotics-are-not-affordable-for-many-in-lmics-and-government-funding-for-health-is-low"><i class="fa fa-check"></i>Barrier 2: Antibiotics are not affordable for many in LMICs and government funding for health is low</a></li>
<li class="chapter" data-level="" data-path="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html"><a href="what-can-be-done-to-ensure-antibiotic-access-in-lmics.html#barrier-3-weak-health-systems-unreliable-supply-chains-and-poor-quality-control-fail-to-deliver-antibiotics-to-patients-in-need"><i class="fa fa-check"></i>Barrier 3: Weak health systems, unreliable supply chains and poor quality control fail to deliver antibiotics to patients in need</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="summary-1.html"><a href="summary-1.html"><i class="fa fa-check"></i>Summary</a></li>
<li class="chapter" data-level="" data-path="lecture-slides-1.html"><a href="lecture-slides-1.html"><i class="fa fa-check"></i>Lecture Slides</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="module-3-antibiotic-and-diagnostic-test-availability-affordability-in-lmics-lessons-learned-from-the-covid-19-pandemic.html"><a href="module-3-antibiotic-and-diagnostic-test-availability-affordability-in-lmics-lessons-learned-from-the-covid-19-pandemic.html"><i class="fa fa-check"></i>Module 3: Antibiotic and diagnostic test availability, affordability in LMICs: Lessons learned from the COVID-19 pandemic</a>
<ul>
<li class="chapter" data-level="" data-path="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html"><a href="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html"><i class="fa fa-check"></i>COVID-19 Vaccine Access in Low-Middle Income Countries (LMICs)</a>
<ul>
<li class="chapter" data-level="" data-path="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html"><a href="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html#covid-19-vaccines-global-access-covax-program"><i class="fa fa-check"></i>COVID-19 Vaccines Global Access (COVAX) Program</a></li>
<li class="chapter" data-level="" data-path="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html"><a href="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html#is-the-covax-program-suceeding"><i class="fa fa-check"></i>Is the COVAX program suceeding?</a></li>
<li class="chapter" data-level="" data-path="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html"><a href="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html#access-to-sars-cov-2-testing-in-lmics"><i class="fa fa-check"></i>Access to SARS-CoV-2 testing in LMICs</a></li>
<li class="chapter" data-level="" data-path="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html"><a href="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html#infection-control-in-lmics"><i class="fa fa-check"></i>Infection control in LMICs</a></li>
<li class="chapter" data-level="" data-path="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html"><a href="covid-19-vaccine-access-in-low-middle-income-countries-lmics.html#intensive-care-units-icus-in-lmics"><i class="fa fa-check"></i>Intensive care units (ICUs) in LMICs</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="access-to-covid-19-tools-accelerator-act.html"><a href="access-to-covid-19-tools-accelerator-act.html"><i class="fa fa-check"></i>ACCESS TO COVID-19 Tools Accelerator (ACT)</a></li>
<li class="chapter" data-level="" data-path="medicines-patent-pool.html"><a href="medicines-patent-pool.html"><i class="fa fa-check"></i>Medicines Patent Pool</a>
<ul>
<li class="chapter" data-level="" data-path="medicines-patent-pool.html"><a href="medicines-patent-pool.html#covid-19"><i class="fa fa-check"></i>COVID-19</a></li>
<li class="chapter" data-level="" data-path="medicines-patent-pool.html"><a href="medicines-patent-pool.html#hivaids"><i class="fa fa-check"></i>HIV/AIDS</a></li>
<li class="chapter" data-level="" data-path="medicines-patent-pool.html"><a href="medicines-patent-pool.html#viral-hepatitis"><i class="fa fa-check"></i>Viral hepatitis</a></li>
<li class="chapter" data-level="" data-path="medicines-patent-pool.html"><a href="medicines-patent-pool.html#tuberculosis"><i class="fa fa-check"></i>Tuberculosis</a></li>
<li class="chapter" data-level="" data-path="medicines-patent-pool.html"><a href="medicines-patent-pool.html#is-the-medicines-patient-pool-working"><i class="fa fa-check"></i>Is the Medicines Patient Pool Working?</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="counterfeit-medications.html"><a href="counterfeit-medications.html"><i class="fa fa-check"></i>Counterfeit Medications</a>
<ul>
<li class="chapter" data-level="" data-path="counterfeit-medications.html"><a href="counterfeit-medications.html#specific-problems-with-counterfeit-antibiotics"><i class="fa fa-check"></i>Specific problems with counterfeit antibiotics</a></li>
<li class="chapter" data-level="" data-path="counterfeit-medications.html"><a href="counterfeit-medications.html#how-can-drug-counterfeiting-be-reduced"><i class="fa fa-check"></i>How can drug counterfeiting be reduced?</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="summary-covid-19-and-lessons-for-the-amr-crises.html"><a href="summary-covid-19-and-lessons-for-the-amr-crises.html"><i class="fa fa-check"></i>Summary: COVID-19 and lessons for the AMR crises</a></li>
<li class="chapter" data-level="" data-path="lecture-slides-2.html"><a href="lecture-slides-2.html"><i class="fa fa-check"></i>Lecture Slides</a></li>
<li class="chapter" data-level="" data-path="references.html"><a href="references.html"><i class="fa fa-check"></i>References</a></li>
</ul></li>
</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">97039 - GLOBAL HEALTH, ANTIMICROBIAL DRUGS AND VACCINES</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="references" class="section level2 unnumbered">
<h2>References</h2>

<div id="refs" class="references csl-bib-body">
<div class="csl-entry">
<div class="csl-left-margin">1 </div><div class="csl-right-inline">Livermore DM, on behalf of the British Society for Antimicrobial Chemotherapy Working Party on The Urgent Need: Regenerating Antibacterial Drug Discovery and Development, Blaser M, <em>et al.</em> <a href="https://doi.org/10.1093/jac/dkr262">Discovery research: The scientific challenge of finding new antibiotics</a>. <em>Journal of Antimicrobial Chemotherapy</em> 2011; <strong>66</strong>: 1941–4.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">2 </div><div class="csl-right-inline">Magiorakos A-P, Srinivasan A, Carey RB, <em>et al.</em> <a href="https://doi.org/10.1111/j.1469-0691.2011.03570.x">Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance</a>. <em>Clinical Microbiology and Infection</em> 2012; <strong>18</strong>: 268–81.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">3 </div><div class="csl-right-inline">Kadri SS, Adjemian J, Lai YL, <em>et al.</em> <a href="https://doi.org/10.1093/cid/ciy378">Difficult-to-<span>Treat Resistance</span> in <span class="nocase">Gram-negative Bacteremia</span> at 173 <span>US Hospitals</span>: <span>Retrospective Cohort Analysis</span> of <span>Prevalence</span>, <span>Predictors</span>, and <span>Outcome</span> of <span>Resistance</span> to <span class="nocase">All First-line Agents</span></a>. <em>Clinical Infectious Diseases</em> 2018; <strong>67</strong>: 1803–14.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">4 </div><div class="csl-right-inline">Van Boeckel TP, Glennon EE, Chen D, <em>et al.</em> <a href="https://doi.org/10.1126/science.aao1495">Reducing antimicrobial use in food animals</a>. <em>Science (New York, NY)</em> 2017; <strong>357</strong>: 1350–2.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">5 </div><div class="csl-right-inline">Holmes AH, Moore LSP, Sundsfjord A, <em>et al.</em> <a href="https://doi.org/10.1016/S0140-6736(15)00473-0">Understanding the mechanisms and drivers of antimicrobial resistance</a>. <em>The Lancet</em> 2016; <strong>387</strong>: 176–87.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">6 </div><div class="csl-right-inline">Center for Disease Dynamics Economics and Policy. The <span>State</span> of the <span>World</span>’s <span>Antibiotics</span> 2021. 2021.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">7 </div><div class="csl-right-inline">Mendelson M, Røttingen J-A, Gopinathan U, <em>et al.</em> <a href="https://doi.org/10.1016/S0140-6736(15)00547-4">Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries</a>. <em>The Lancet</em> 2016; <strong>387</strong>: 188–98.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">8 </div><div class="csl-right-inline">Klein EY, Milkowska-Shibata M, Tseng KK, <em>et al.</em> <a href="https://doi.org/10.1016/S1473-3099(20)30332-7">Assessment of <span>WHO</span> antibiotic consumption and access targets in 76 countries, 2000: An analysis of pharmaceutical sales data</a>. <em>The Lancet Infectious Diseases</em> 2021; <strong>21</strong>: 107–15.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">9 </div><div class="csl-right-inline">Bürgmann H, Frigon D, H Gaze W, <em>et al.</em> Water and sanitation: An essential battlefront in the war on antimicrobial resistance. <em>FEMS microbiology ecology</em> 2018; <strong>94</strong>. DOI:<a href="https://doi.org/10.1093/femsec/fiy101">10.1093/femsec/fiy101</a>.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">10 </div><div class="csl-right-inline">Denny L. <span>BSAC Vanguard Series</span>: <span>Clean</span> waterthe world’s best medicine for disease and drug-resistant infection. <em>Journal of Antimicrobial Chemotherapy</em> 2021; published online Nov. DOI:<a href="https://doi.org/10.1093/jac/dkab414">10.1093/jac/dkab414</a>.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">11 </div><div class="csl-right-inline">Jit M, Ananthakrishnan A, McKee M, Wouters OJ, Beutels P, Teerawattananon Y. Multi-country collaboration in responding to global infectious disease threats: Lessons for <span>Europe</span> from the <span>COVID-19</span> pandemic. <em>The Lancet Regional Health  Europe</em> 2021; <strong>9</strong>. DOI:<a href="https://doi.org/10.1016/j.lanepe.2021.100221">10.1016/j.lanepe.2021.100221</a>.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">12 </div><div class="csl-right-inline">Woolhouse MEJ, Gowtage-Sequeria S. <a href="https://doi.org/10.3201/eid1112.050997">Host range and emerging and reemerging pathogens</a>. <em>Emerging Infectious Diseases</em> 2005; <strong>11</strong>: 1842–7.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">13 </div><div class="csl-right-inline">McEwen SA, Collignon PJ. <a href="https://doi.org/10.1128/microbiolspec.ARBA-0009-2017">Antimicrobial <span>Resistance</span>: A <span>One Health Perspective</span></a>. <em>Microbiology Spectrum</em> 2018; <strong>6</strong>: 6.2.10.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">14 </div><div class="csl-right-inline">Lazarus B, Paterson DL, Mollinger JL, Rogers BA. <a href="https://doi.org/10.1093/cid/ciu785">Do human extraintestinal <span>Escherichia</span> coli infections resistant to expanded-spectrum cephalosporins originate from food-producing animals? <span>A</span> systematic review</a>. <em>Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America</em> 2015; <strong>60</strong>: 439–52.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">15 </div><div class="csl-right-inline">Smith KE, Medus C, Meyer SD, <em>et al.</em> <a href="https://doi.org/10.4315/0362-028X-71.10.2153">Outbreaks of <span>Salmonellosis</span> in <span>Minnesota</span> (1998 through 2006) <span>Associated</span> with <span>Frozen</span>, <span>Microwaveable</span>, <span>Breaded</span>, <span>Stuffed Chicken Products</span></a>. <em>Journal of Food Protection</em> 2008; <strong>71</strong>: 2153–60.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">16 </div><div class="csl-right-inline">Canada PHA of. <span>ARCHIVED</span> - <span>UPDATE</span> - <span>Salmonella Heidelberg Ceftiofur-Related Resistance</span> in <span>Human</span> and <span>Retail Chicken Isolates</span> - 2006 to 2008. 2009; published online March.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">17 </div><div class="csl-right-inline">Endtz HPh, Ruijs GJ, van Klingeren B, Jansen WH, van der Reyden T, Mouton RP. <a href="https://doi.org/10.1093/jac/27.2.199">Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine</a>. <em>Journal of Antimicrobial Chemotherapy</em> 1991; <strong>27</strong>: 199–208.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">18 </div><div class="csl-right-inline">Liu Y-Y, Wang Y, Walsh TR, <em>et al.</em> <a href="https://doi.org/10.1016/S1473-3099(15)00424-7">Emergence of plasmid-mediated colistin resistance mechanism <span>MCR-1</span> in animals and human beings in <span>China</span>: A microbiological and molecular biological study</a>. <em>The Lancet Infectious Diseases</em> 2016; <strong>16</strong>: 161–8.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">19 </div><div class="csl-right-inline">Laxminarayan R, Duse A, Wattal C, <em>et al.</em> <a href="https://doi.org/10.1016/S1473-3099(13)70318-9">Antibiotic resistancethe need for global solutions</a>. <em>The Lancet Infectious Diseases</em> 2013; <strong>13</strong>: 1057–98.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">20 </div><div class="csl-right-inline">Zurfuh K, Poirel L, Nordmann P, Nüesch-Inderbinen M, Hächler H, Stephan R. <a href="https://doi.org/10.1128/AAC.00066-16">Occurrence of the <span>Plasmid-Borne</span> mcr-1 <span>Colistin Resistance Gene</span> in <span>Extended-Spectrum-<span class="math inline">\(\beta\)</span>-Lactamase-Producing Enterobacteriaceae</span> in <span>River Water</span> and <span>Imported Vegetable Samples</span> in <span>Switzerland</span></a>. <em>Antimicrobial Agents and Chemotherapy</em>; <strong>60</strong>: 2594–5.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">21 </div><div class="csl-right-inline">Borowiak M, Fischer J, Hammerl JA, Hendriksen RS, Szabo I, Malorny B. <a href="https://doi.org/10.1093/jac/dkx327">Identification of a novel transposon-associated phosphoethanolamine transferase gene, mcr-5, conferring colistin resistance in d-tartrate fermenting <span>Salmonella</span> enterica subsp. Enterica serovar <span>Paratyphi B</span></a>. <em>The Journal of Antimicrobial Chemotherapy</em> 2017; <strong>72</strong>: 3317–24.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">22 </div><div class="csl-right-inline">Frost I, Van Boeckel TP, Pires J, Craig J, Laxminarayan R. <a href="https://doi.org/10.1093/jtm/taz036">Global geographic trends in antimicrobial resistance: The role of international travel</a>. <em>Journal of Travel Medicine</em> 2019; <strong>26</strong>: taz036.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">23 </div><div class="csl-right-inline">O’Neil J. Antimicrobials in agriculture and the environment: Reducing unnecessary use and waste.<span>The</span> review on antimicrobial resistance. 2015.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">24 </div><div class="csl-right-inline">Rahube TO, Marti R, Scott A, <em>et al.</em> <a href="https://doi.org/10.1139/cjm-2016-0034">Persistence of antibiotic resistance and plasmid-associated genes in soil following application of sewage sludge and abundance on vegetables at harvest</a>. <em>Canadian Journal of Microbiology</em> 2016; <strong>62</strong>: 600–7.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">25 </div><div class="csl-right-inline">Singer AC, Shaw H, Rhodes V, Hart A. Review of antimicrobial resistance in the environment and its relevance to environmental regulators. <em>Frontiers in Microbiology</em> 2016; <strong>7</strong>. DOI:<a href="https://doi.org/10.3389/fmicb.2016.01728">10.3389/fmicb.2016.01728</a>.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">26 </div><div class="csl-right-inline">Bush K, Jacoby GA. <a href="https://doi.org/10.1128/AAC.01009-09">Updated <span>Functional Classification</span> of <span><span class="math inline">\(\beta\)</span></span>-<span>Lactamases</span></a>. <em>Antimicrobial Agents and Chemotherapy</em> 2010; <strong>54</strong>: 969–76.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">27 </div><div class="csl-right-inline">Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL. <a href="https://doi.org/10.1038/nrd2201">Drugs for bad bugs: Confronting the challenges of antibacterial discovery</a>. <em>Nature reviews Drug discovery</em> 2007; <strong>6</strong>: 29–40.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">28 </div><div class="csl-right-inline">Kållberg C, Årdal C, Blix HS, <em>et al.</em> <a href="https://doi.org/10.1371/journal.pone.0205166">Introduction and geographic availability of new antibiotics approved between 1999 and 2014</a>. <em>PLOS ONE</em> 2018; <strong>13</strong>: e0205166.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">29 </div><div class="csl-right-inline">Daulaire N, Bang A, Tomson G, Kalyango JN, Cars O. <a href="https://doi.org/10.1111/jlme.12269">Universal <span>Access</span> to <span>Effective Antibiotics</span> is <span>Essential</span> for <span>Tackling Antibiotic Resistance</span></a>. <em>Journal of Law, Medicine &amp; Ethics</em> 2015/ed; <strong>43</strong>: 17–21.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">30 </div><div class="csl-right-inline">Outterson K, Orubu ESF, Rex J, Årdal C, Zaman MH. <a href="https://doi.org/10.1093/cid/ciab612">Patient <span>Access</span> in 14 <span>High-Income Countries</span> to <span>New Antibacterials Approved</span> by the <span>US Food</span> and <span>Drug Administration</span>, <span>European Medicines Agency</span>, <span>Japanese Pharmaceuticals</span> and <span>Medical Devices Agency</span>, or <span>Health Canada</span>, 2010</a>. <em>Clinical Infectious Diseases</em> 2021; : ciab612.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">31 </div><div class="csl-right-inline">Wouters OJ, McKee M, Luyten J. <a href="https://doi.org/10.1001/jama.2020.1166">Estimated <span>Research</span> and <span>Development Investment Needed</span> to <span>Bring</span> a <span>New Medicine</span> to <span>Market</span>, 2009-2018</a>. <em>JAMA</em> 2020; <strong>323</strong>: 844–53.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">32 </div><div class="csl-right-inline">Echols R, Ariyasu M, Nagata TD. <a href="https://doi.org/10.1093/cid/ciz829">Pathogen-focused <span>Clinical Development</span> to <span>Address Unmet Medical Need</span>: <span>Cefiderocol Targeting Carbapenem Resistance</span></a>. <em>Clinical Infectious Diseases</em> 2019; <strong>69</strong>: S559–64.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">33 </div><div class="csl-right-inline">Mauri L, D’Agostino RB Sr. <a href="https://doi.org/10.1056/NEJMra1510063">Challenges in the <span>Design</span> and <span>Interpretation</span> of <span>Noninferiority Trials</span></a>. <em>The New England journal of medicine</em> 2017; <strong>377</strong>: 1357–67.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">34 </div><div class="csl-right-inline">DiNubile MJ. <a href="https://doi.org/10.1093/ofid/ofw110">Noninferior <span>Antibiotics</span>: <span>When Is</span> <span>‘<span>Not Bad</span>’</span> <span>‘<span>Good Enough</span>’</span>?</a> <em>Open Forum Infectious Diseases</em> 2016; <strong>3</strong>: ofw110.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">35 </div><div class="csl-right-inline">McKenna M. <a href="https://doi.org/10.1038/d41586-020-02418-x">The antibiotic paradox: Why companies can’t afford to create life-saving drugs</a>. <em>Nature</em> 2020; <strong>584</strong>: 338–41.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">36 </div><div class="csl-right-inline">Årdal C, Balasegaram M, Laxminarayan R, <em>et al.</em> <a href="https://doi.org/10.1038/s41579-019-0293-3">Antibiotic development  economic, regulatory and societal challenges</a>. <em>Nature Reviews Microbiology</em> 2020; <strong>18</strong>: 267–74.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">37 </div><div class="csl-right-inline">Mullard A. <a href="https://doi.org/10.1038/d41573-019-00085-w">Achaogen bankruptcy highlights antibacterial development woes</a>. <em>Nature Reviews Drug Discovery</em> 2019; <strong>18</strong>: 411.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">38 </div><div class="csl-right-inline">Gotham D, Moja L, van der Heijden M, Paulin S, Smith I, Beyer P. <a href="https://doi.org/10.1016/j.healthpol.2020.11.015">Reimbursement models to tackle market failures for antimicrobials: <span>Approaches</span> taken in <span>France</span>, <span>Germany</span>, <span>Sweden</span>, the <span>United Kingdom</span>, and the <span>United States</span></a>. <em>Health Policy</em> 2021; <strong>125</strong>: 296–306.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">39 </div><div class="csl-right-inline">Shafiq N, Pandey AK, Malhotra S, <em>et al.</em> <a href="https://doi.org/10.1136/bmjgh-2021-006961">Shortage of essential antimicrobials: A major challenge to global health security</a>. <em>BMJ Global Health</em> 2021; <strong>6</strong>: e006961.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">40 </div><div class="csl-right-inline">Do NTT, Vu HTL, Nguyen CTK, <em>et al.</em> <a href="https://doi.org/10.1016/S2214-109X(21)00024-3">Community-based antibiotic access and use in six low-income and middle-income countries: A mixed-method approach</a>. <em>The Lancet Global Health</em> 2021; <strong>9</strong>: e610–9.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">41 </div><div class="csl-right-inline">Frost I, Craig J, Joshi J, Faure K, Laxminarayan R. Access <span>Barriers</span> to <span>Antibiotics</span>. <span>Center for Disease Dynamics, Economics &amp; Policy (CDDEP)</span>, 2019.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">42 </div><div class="csl-right-inline">Erfani P, Binagwaho A, Jalloh MJ, Yunus M, Farmer P, Kerry V. <a href="https://doi.org/10.1136/bmj.n1837">Intellectual property waiver for covid-19 vaccines will advance global health equity</a>. <em>BMJ</em> 2021; <strong>374</strong>: n1837.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">43 </div><div class="csl-right-inline">Pasquale S, Gregorio GL, Caterina A, <em>et al.</em> <a href="https://doi.org/10.3390/vaccines9121477"><span>COVID-19</span> in <span>Low-</span> and <span>Middle-Income Countries</span> (<span>LMICs</span>): <span>A Narrative Review</span> from <span>Prevention</span> to <span>Vaccination Strategy</span></a>. <em>Vaccines</em> 2021; <strong>9</strong>: 1477.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">44 </div><div class="csl-right-inline">Delepierre A, Gayot A, Carpentier A. <a href="https://doi.org/10.1016/j.medmal.2012.04.007">Update on counterfeit antibiotics worldwide; <span>Public</span> health risks</a>. <em>Médecine et Maladies Infectieuses</em> 2012; <strong>42</strong>: 247–55.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">45 </div><div class="csl-right-inline">Group MQR. Medical <span>Product Quality Report</span>  <span>COVID-19 Issues</span>. 2021.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">46 </div><div class="csl-right-inline">Srivastava K. <a href="https://doi.org/10.1136/bmj.n2754">Fake covid vaccines boost the black market for counterfeit medicines</a>. <em>BMJ</em> 2021; <strong>375</strong>: n2754.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">47 </div><div class="csl-right-inline">Delepierre A, Gayot A, Carpentier A. <a href="https://doi.org/10.1016/j.medmal.2012.04.007">Update on counterfeit antibiotics worldwide; <span>Public</span> health risks</a>. <em>Médecine et Maladies Infectieuses</em> 2012; <strong>42</strong>: 247–55.</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">48 </div><div class="csl-right-inline">Global Antibiotic Resaerch and Development Partnership. Learning from <span>COVID-19</span> to <span>Tackle Antibiotic Resistance</span>. 2020.</div>
</div>
</div>
</div>
<!-- </div> -->
            </section>

          </div>
        </div>
      </div>
<a href="lecture-slides-2.html" class="navigation navigation-prev navigation-unique" aria-label="Previous page"><i class="fa fa-angle-left"></i></a>

    </div>
  </div>
<script src="assets/gitbook-2.6.7/js/app.min.js"></script>
<script src="assets/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="assets/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="assets/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="assets/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="assets/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="assets/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="assets/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"whatsapp": false,
"all": ["facebook", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": null,
"text": null
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": null,
"search": {
"engine": "fuse",
"options": null
},
"toc": {
"collapse": "subsection"
},
"toolbar": {
"position": "static"
}
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
